IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
160.13
-2.67 (-1.64%)
At close: Jul 14, 2025, 4:00 PM
160.13
0.00 (0.00%)
After-hours: Jul 14, 2025, 4:10 PM EDT
IQVIA Holdings Employees
IQVIA Holdings had 88,000 employees as of December 31, 2024. The number of employees increased by 1,000 or 1.15% compared to the previous year.
Employees
88,000
Change (1Y)
1,000
Growth (1Y)
1.15%
Revenue / Employee
$176,102
Profits / Employee
$15,159
Market Cap
27.69B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 88,000 | 1,000 | 1.15% |
Dec 31, 2023 | 87,000 | 1,000 | 1.16% |
Dec 31, 2022 | 86,000 | 7,000 | 8.86% |
Dec 31, 2021 | 79,000 | 9,000 | 12.86% |
Dec 31, 2020 | 70,000 | 3,000 | 4.48% |
Dec 31, 2019 | 67,000 | 9,000 | 15.52% |
Dec 31, 2018 | 58,000 | 3,000 | 5.45% |
Dec 31, 2017 | 55,000 | 5,000 | 10.00% |
Dec 31, 2016 | 50,000 | 13,900 | 38.50% |
Dec 31, 2015 | 36,100 | 3,500 | 10.74% |
Dec 31, 2014 | 32,600 | 4,400 | 15.60% |
Dec 31, 2013 | 28,200 | 788 | 2.87% |
Dec 31, 2012 | 27,412 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IQV News
- 13 days ago - IQVIA to Announce Second-Quarter 2025 Results on July 22, 2025 - Business Wire
- 4 weeks ago - IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement' - Business Wire
- 4 weeks ago - IQVIA Launches New AI Agents for Life Sciences and Healthcare - Business Wire
- 4 weeks ago - IQVIA Stock: Stuck In A Time Spiral - Value Play Or Bull Trap? - Benzinga
- 6 weeks ago - IQVIA Announces Pricing of Senior Notes - Business Wire
- 6 weeks ago - IQVIA Announces Offering of Senior Notes - Business Wire
- 6 weeks ago - Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - PRNewsWire
- 2 months ago - IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials - Business Wire